Evidence map›Paper›PMID 11850813›Full record

ArticleOncogene2002

ATM-dependent activation of the gene encoding MAP kinase phosphatase 5 by radiomimetic DNA damage.

Anat Bar-Shira, Sharon Rashi-Elkeles, Liat Zlochover, Lilach Moyal, Nechama I Smorodinsky, Rony Seger, Yosef Shiloh

Abstract read
PubMed Publisher
In one paragraph

Article in Oncogene, 2002. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 33 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. ATM and ATR: sensing DNA damage.World journal of gastroenterology · 2004
    Review
  11. Review
  12. Review
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Anat Bar-ShiraThe David and Inez Myers Laboratory for Genetic Research, Department of Human Genetics and Molecular Medicine, Sackler School of Medicine, Tel Aviv University, Tel Aviv 69978, Israel.
Sharon Rashi-Elkeles
Liat Zlochover
Lilach Moyal
Nechama I Smorodinsky
Rony Seger
Yosef Shiloh
Tel Aviv University · ILWeizmann Institute of Science · IL

Funding

ATAXIA-TELANGIECTASIS: FROM GENE BACK TO PHENOTYPER01NS031763 · NINDS · TEL AVIV UNIVERSITY · PI SHILOH, YOSEF · 1994 to 2005
$1.1M
NINDS NIH HHS R01 NS31763
6 · The paper itself

Abstract

Cellular responses to DNA damage are mediated by an extensive network of signaling pathways. The ATM protein kinase is a master regulator of the response to double-strand breaks (DSBs), the most cytotoxic DNA lesion caused by ionizing radiation. ATM is the protein missing or inactive in patients with the pleiotropic genetic disorder ataxia-telangiectasia (A-T). A major response to DNA damage is altered expression of numerous genes. While studying gene expression in control and A-T cells following treatment with the radiomimetic chemical neocarzinostatin (NCS), we identified an expressed sequence tag that represented a gene that was induced by DSBs in an ATM-dependent manner. The corresponding cDNA encoded a dual specificity phosphatase of the MAP kinase phosphatase family, MKP-5. MKP-5 dephosphorylates and inactivates the stress-activated MAP kinases JNK and p38. The phosphorylation-dephosphorylation cycle of JNK and p38 by NCS was attenuated in A-T cells. Thus, ATM modulates this cycle in response to DSBs. These results further highlight ATM as a link between the DNA damage response and major signaling pathways involved in proliferative and apoptotic processes.

Indexed as

DNA DamageTranscriptional ActivationAtaxia TelangiectasiaAtaxia Telangiectasia Mutated ProteinsCell Cycle ProteinsCell LineDNA-Binding ProteinsDual-Specificity PhosphatasesEnzyme ActivationGene DeletionHumansIntracellular Signaling Peptides and ProteinsJNK Mitogen-Activated Protein KinasesKineticsMitogen-Activated Protein Kinase PhosphatasesMitogen-Activated Protein KinasesAtaxia Telangiectasia Mutated ProteinsATM protein, humanCell Cycle ProteinsDNA-Binding ProteinsDual-Specificity PhosphatasesDUSP10 protein, humanIntracellular Signaling Peptides and ProteinsJNK Mitogen-Activated Protein KinasesMitogen-Activated Protein Kinase PhosphatasesMitogen-Activated Protein Kinasesp38 Mitogen-Activated Protein KinasesProtein Serine-Threonine KinasesProtein Tyrosine PhosphatasesRNA, MessengerTumor Suppressor ProteinsZinostatin

Identifiers

PMID11850813
OpenAlexW2315255667

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.